Table 1.
Compounds | Experimental Models | Dosage and Administration | Effects | Ref |
---|---|---|---|---|
Curcumin | LPS-induced BV2 cells | 1, 5, and 10μM | ↓ NO, IL-1β, IL-6, iNOS ↑ IL-4, IL-10, Arg-1 promoted microglial polarization to the M2 phenotype |
[8] |
Curcumin | Subarachnoid hemorrhage mice models | 100mg/kg, i.p. | ↓ IL-1β, IL-6, iNOS, and TNF-α, CD86 protein, ↑ IL-10, TGF-β ↓ TLR4 signaling |
[9] |
Curcumin | Cigarette smoke extract-treated Beas-2B cells | 2.5, 5 and 7.5μM | ↑ PPAR-γ, ↓ NF-κB |
[11] |
Curcumin | Cigarette smoke-induced COPD rat models | 100mg/kg, i.g. | ↑ PPAR-γ, ↓ NF-κB, inflammation score ↓TNF-α, IL-6 |
[11] |
Curcumin | Gp120-induced BV2 cells | 10 μM | ↓ MCP-1, IL-17 | [17] |
Curcumin | LPS-induced inflammation in vascular smooth muscle cells | 5, 10, 30 μmol/L for 24 h | ↓ MCP-1, TNF-α, iNOS, NO ↓ ROS |
[19] |
Curcumin | Palmitate-induced inflammation in skeletal muscle C2C12 cells | 40 μM | ↓ TNF-α, IL-6 ↓ ROS |
[20] |
Curcumin | TNBS-Induced Colitis Rats | 100mg/kg, i.g. | ↓ TLR4, NF-κB, IL-27 | [21] |
Curcumin | dextran sulfate sodium-induced colitis mice | 100 mg/kg, i.g. | ↓ IL-6, IL-17, IL-23 ↑ IL-10 regulating the Re-equilibration of Treg/Th17 |
[30] |
Curcumin | DSS-induced colitis mouse model | 100 mg/kg, intraperitoneally injected | ↓ IL-1β, IL-6, MCP-1 | [35] |
Curcumin | DSS-induced ulcerative colitis mice model | 50 mg/kg, standard diet supplemented | ↓ TNF-α, IL-6 | [44] |
Curcumin | DSS-induced acute colitis in mice | 15, 30, 60 mg/kg, intraperitoneally injected | ↓ TNF-α, IL-6, IL-17 ↑ IL-10 |
[45] |
Curcumin Curcumin nanoparticles |
Post-traumatic osteoarthritis mouse model | 50 mg/kg, i.g. 0.07 mg of 10 μg curcumin/1 mg nanoparticles, topical application |
↓ MMP-1, MMP-3, MMP-13, ADAMTS5, IL-1β, TNF-α | [57] |
Acid-activatable curcumin polymer | Monoiodoacetic acid-induced osteoarthritis mouse model | 2.5, 5 mg/kg, intramuscular injection | ↓ IL-1β, TNF-α | [58] |
Curcumin | Collagen-induced rat arthritis model | 100, 200 mg/kg, oral | ↓ TNF-α, IL-17, IL-1β and TGF-β | [59] |
Curcumin | Anterior cruciate ligament transection rat model | 50μL, Intra-articular administration |
↓ IL-1β, TNF-ɑ | [61] |
Curcumin loaded hyalurosomes | Fibroblast-like synovial cells | ↑ IL-10 ↓ IL-6, IL-15, TNF-ɑ |
[68] | |
Curcumin | Primary rat abdominal macrophages MSU-induced gouty arthritis rat model |
1 μM 100, 150, 200 mg/kg, intraperitoneal administration |
↓ IL-1β, TNF-α, NLRP3, caspase‐1 | [70] |
Curcumin | Imiquimod-induced differentiated HaCaT cells | 25, 50 µM | ↓ IL-17, TNF-ɑ, IL-6, IFN-γ | [80] |
Curcumin | Transgenic mouse model of psoriasis | 40 mg/kg | ↓ IFN-γ, TNF-α, IL-2, IL-12, IL-22, IL-23 | [82] |
Curcumin | TPA-induced K14-VEGF transgenic psoriasis | Topical 50mg/cm2 curcumin gel, twice daily | ↓ IFN-γ | [83] |
Curcumin nanohydrogel | imiquimod-induced psoriasis model | ↓ TNF-α, iNOS | [84] | |
Curcumin | Chronic unpredictable mild stress-induced rats model | 100 mg/kg, daily | ↓ IL-1β, IL-6, TNF-α ↓ NF-κB activation ↓stressed-induced P2X7R/NLRP3 inflammasome axis activation |
[102] |
Curcumin | Chronic unpredictable mild stress-induced rats model | 20mg/kg, oral | ↓ IL-6, TNF-α | [103] |
Curcumin | CUMS depression model | 40 mg/kg, i.p. | ↓ IL-1β | [104] |
Curcumin | ApoE-/- mice | 0.1% w/w, diet addition | ↓ TLR4, IL-1β, TNF-α, VCAM-1, ICAM-1, NF-κB, | [122] |
Mannich Curcuminoids |
TNBS-induced colitis rats model | 40 mg/kg, orally | ↓ NF-κB, IL-6, IL-4, TNF-α | [149] |
TRB-N0224 | A rabbit anterior cruciate ligament transection injury-induced model of OA. | 25, 50 mg/kg/day | ↓IL-1β, IL-6, TNF-α, MMP-9, MMP-13 | [150] |
Curcumin analogue AI-44 | MSU-induced THP-1 cell | 3 μM | ↓TNF-α, IL-1β | [157] |
Curcumin diglutaric acid | LPS-stimulated RAW 264.7 macrophage cells | 1, 5, 10, 20, and 50 µM | ↓ NO, IL-6, TNF-α, iNOS, COX-2 | [160] |
Curcumin-galactomannoside (CGM) | Acetic acid-induced colitis | 250 mg/kg bwt | ↓ COX-2, PGE2, iNOS, TLR4, IL-6, TNF-α | [171] |
Next Generation Ultrasol Curcumin (NGUC) | MIA-induced OA | 1100, 2200 mg/kg(20, 40 mg/kg of curcuminoids) | ↓ TNF-α, IL-1β, IL-6, COMP, CRP, MMP-3, 5-LOX, COX-2, NF-κB | [174] |